Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Glioma 1Glioblastoma 1Breast Neoplasms 1

Interventions

Standard of Care 23Specimen Handling 20Practice Guidelines as Topic 17Interviews as Topic 17Methods 15Educational Status 15Early Intervention, Educational 14Exercise 13Blood Specimen Collection 11Magnetic Resonance Spectroscopy 10Surveys and Questionnaires 8Patient Navigation 8Radiosurgery 7Palliative Care 7Radiotherapy 6Counseling 6Surgical Procedures, Operative 5Resistance Training 5Nutrition Assessment 5X-Rays 4Therapeutics 4Health Promotion 4Diet Therapy 4Biopsy 4Acupressure 4Robotic Surgical Procedures 3Radiation Dose Hypofractionation 3Radiation 3Positron-Emission Tomography 3Paclitaxel 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × 4-amino-4'-hydroxylaminodiphenylsulfone × 30 days × Clear all
NCT03975959 2026-06-04

PROMESSE

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Completed
426 enrolled
BreastCNS

Breast Neoplasms, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡